RMD

ResMed Secures Significant Victory in Patent Fight Against New York University

Retrieved on: 
Monday, December 11, 2023
ASX, Invention, Research, NYU, SAN, RMD, Patent, ResMed, Patient, PTAB, District court

SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) announced that it has secured a significant victory after the United States Patent Trial and Appeals Board (PTAB) invalidated the claims New York University (NYU) asserted against ResMed, based on seven NYU patents.

Key Points: 
  • SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) announced that it has secured a significant victory after the United States Patent Trial and Appeals Board (PTAB) invalidated the claims New York University (NYU) asserted against ResMed, based on seven NYU patents.
  • In June 2021, NYU filed a complaint for patent infringement against ResMed in the United States District Court, District of Delaware.
  • NYU’s complaint alleged that the AutoSetTM and AutoRampTM features of ResMed’s AirSenseTM 10 AutoSet flow generators, infringed one or more claims of seven NYU patents.
  • ResMed filed petitions with the PTAB asserting that all the claims asserted against ResMed were invalid.

Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally

Retrieved on: 
Thursday, December 7, 2023
Urinary tract infection, JAMA, ASX, Risk, Woman, COPD, Prevalence, Disease, Lung cancer, SAN, RMD, Education, Gestational sac, Low, Air pollution, Emphysema, Chronic obstructive pulmonary disease, American Medical Association, JAMA Network Open, Tobacco smoking, World Health Organization, ResMed, Growth, Patient, Bronchitis, Journal, Female, Dust, Pharmaceutical industry

According to the World Health Organization , COPD is the third deadliest disease in the world.

Key Points: 
  • According to the World Health Organization , COPD is the third deadliest disease in the world.
  • Today, there are an estimated 480 million people who suffer from COPD.
  • This study in JAMA Network Open projects the increased regional and global burden of COPD by 2050 through an analysis of historical COPD prevalence and data on COPD risk factors such as tobacco smoking, outdoor air pollution, and household air pollution.
  • “The disproportionate growth of COPD among women is a critical finding as COPD has not always been as prevalent in women.

ResMed Adopts New Operating Model to Accelerate Long-term Growth

Retrieved on: 
Thursday, November 9, 2023
ResMed, NYSE, SAN, RMD, Culture, ASX, Retirement, Growth, Urvashi, Sales, Film industry, Management

SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced a new operating model to accelerate long-term growth.

Key Points: 
  • SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced a new operating model to accelerate long-term growth.
  • The new operating model introduces dedicated leadership in Product, Revenue, and Marketing to the global executive team.
  • Ultimately, the goal is to accelerate profitable growth, while driving greater value and improved care throughout the outside hospital care continuum and the patient journey.
  • I’m more excited than ever about ResMed’s future, the changes we’ve made position us well to accelerate profitable growth for the benefit of all stakeholders.”

Orion Unveils Advisor Trading and Enhanced Schwab Integration at IMPACT® 2023

Retrieved on: 
Tuesday, October 24, 2023
Software, Personal Finance, Data Analytics, Asset Management, Consulting, Professional Services, Technology, Fintech, RIA, Salesforce, MMF, RMD, Adviser, Financial adviser, Schwab, Eclipse, Red tail

With IMPACT® kicking off today in Philadelphia, Orion Advisor Solutions announced major integration innovations: the launch of an enhanced Schwab Advisor Services custodial integration featuring real-time data and a new Advisor Trading experience, including enhanced advisor trading workflows and automated Schwab money market fund investing.

Key Points: 
  • With IMPACT® kicking off today in Philadelphia, Orion Advisor Solutions announced major integration innovations: the launch of an enhanced Schwab Advisor Services custodial integration featuring real-time data and a new Advisor Trading experience, including enhanced advisor trading workflows and automated Schwab money market fund investing.
  • To save advisor teams even more time, Orion has integrated this functionality into both Redtail and the Orion Advisor Portal.
  • Additionally, Orion announced a single-sign-on integration between the Orion Client Portal and Schwab Alliance, the Schwab Advisor Services portal specifically for clients of advisors.
  • Both the Schwab Alliance integration and the new custodial dashboard are also available to Redtail users via the Orion integration.

Wolters Kluwer shares tax expertise for looming required minimum distribution changes

Retrieved on: 
Tuesday, September 19, 2023
Accounting, Professional Services, Finance, IRAS, IRS, Failure, Average revenue per user, Internal Revenue Service, TAA, Secure, RMD, Wolters Kluwer, IRA, Person, Human voice, Reuters, SECURE Act, Retirement, JD, CPA, Ageing, Death, Legislation, Financial adviser, Cryptocurrency, Life insurance

That’s according to experts at Wolters Kluwer Tax & Accounting (TAA) who are on hand to discuss the changes due to legislation called the Secure Act 2.0, passed on December 29, 2022.

Key Points: 
  • That’s according to experts at Wolters Kluwer Tax & Accounting (TAA) who are on hand to discuss the changes due to legislation called the Secure Act 2.0, passed on December 29, 2022.
  • September 30, 2023 is the deadline to rollover mischaracterized required minimum distributions and avoid current taxation for people aged 72.
  • Penalty relief is available for certain inherited IRA recipients who failed to make required minimum distributions in 2021, 2022, and 2023.
  • Wolters Kluwer TAA enables tax and accounting professionals and businesses of all sizes to drive productivity, navigate change, and deliver better outcomes.

ResMed Announces Participation in Upcoming Conferences

Retrieved on: 
Tuesday, September 5, 2023
Sheraton New York Times Square Hotel, RMD, ASX, ResMed, SAN, Morgan, Bank, Conference, NYSE, Drug

SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced its participation in two upcoming conferences.

Key Points: 
  • SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced its participation in two upcoming conferences.
  • Mick Farrell, chief executive officer and chair of the board, and Brett Sandercock, chief financial officer, will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference on Tuesday, September 12, 2023, beginning at approximately 10:50 a.m. (Eastern Daylight Time) at the Sheraton New York Times Square in New York, NY.
  • More information about these events, including access to the live, audio-only webcasts, may be accessed by visiting https://investor.resmed.com .
  • The audio-only webcast replays will be available approximately 24 hours after the live webcasts end and will be accessible for the following 180 days.

Advyzon Investment Management (AIM) Adds Fidelity, Alpha Vee Solutions, KKM Financial, and Zacks

Retrieved on: 
Wednesday, August 16, 2023
Bachelor of Science in Hospitality & Catering Management, CFA, Senior, MBA, Oranje Locks, Series 7, Practice management, University of Illinois Urbana-Champaign, ESG, Business development, AIM, University, FNZ, Research, Zacks, Fidelity Investments, Tamaulipas, Philosophy, KKM, CRM, Fidelity, ETF, NOT, RMD, Business, Capital Group Companies, RIAS, You, TAMP, AllianceBernstein, DCA, Spinal muscular atrophies, Uniform Securities Agent State Law Exam, Sale, IBD, SS, Financial adviser, Financial services, Cryptocurrency, Management, Nucleus

CHICAGO, Aug. 16, 2023 /PRNewswire/ -- Advyzon Investment Management (AIM), a turnkey asset management program (TAMP) under the Advyzon umbrella, recently added multiple new asset managers to their platform, including Fidelity Investments, Alpha Vee Solutions, KKM Financial, and Zacks Investment Management.

Key Points: 
  • CHICAGO, Aug. 16, 2023 /PRNewswire/ -- Advyzon Investment Management (AIM), a turnkey asset management program (TAMP) under the Advyzon umbrella, recently added multiple new asset managers to their platform, including Fidelity Investments , Alpha Vee Solutions , KKM Financial , and Zacks Investment Management .
  • Fidelity, Alpha Vee, KKM, Zacks, Davis Selected Advisors, PMV Capital, Next Century Growth Investors, and Unified Investment Management join existing managers Advyzon Investment Management, Taylor Frigon Capital Management, WCM Investment Management, AllianceBernstein, WealthTrust Asset Management, Trademark Capital Management, Passage Global Capital Management, Principal Asset Management, Evestia Financial, Integrated Capital Management, Berkshire Asset Management, and Palisades Investment Partners, with more managers and strategies coming in the near future.
  • "Zacks Investment Management is very excited to be a part of Advyzon's new model marketplace," said Greg Murphy, Managing Director of National Sales at Zacks.
  • "Alpha Vee Solutions is excited to join Advyzon's model marketplace," said Leigh Eichel, CEO of Alpha Vee.

ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software

Retrieved on: 
Wednesday, July 5, 2023
King & Spalding, COPD, Acute HME syndrome, Partnership, Sleep, RMD, ASX, OSA, ResMed, Acquisition, Patient, Physician, SAN, PAP, Diagnosis, Ecosystem, Health, Piper, DLA Piper, NYSE, Nursing

“We are thrilled to welcome the Somnoware team to ResMed,” said ResMed Sleep & Respiratory Care President Lucile Blaise.

Key Points: 
  • “We are thrilled to welcome the Somnoware team to ResMed,” said ResMed Sleep & Respiratory Care President Lucile Blaise.
  • Improving patients’ experience and health outcomes is our common goal.”
    “We are very excited about this acquisition,” said ResMed North America General Manager Bill Shoop.
  • “Somnoware’s offering has been well received in the marketplace and it naturally complements our ecosystem of digital solutions across the patient care pathway.
  • Our partnership will open new avenues to help physicians with the critical task of chronic care management,” said Subath Kamalasan, Somnoware cofounder and CEO.

PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP

Retrieved on: 
Thursday, June 8, 2023
Abstract, Male, ER, Heart, Heart failure, Bed, Sleep, RMD, Woman, ASX, Sleep apnea, OSA, ResMed, Doctor of Philosophy, Insomnia, Hospital, Patient, Risk, Master of Science, PAP, ERS, Obstructive sleep apnea, NYSE, Fatigue, Pharmaceutical industry, Birth control, Nursing

One retrospective study showed people with OSA and systolic heart failure and adherent to PAP had 24% fewer ER visits and incurred 40% lower costs related to hospitalizations and ER visits over 1 year ($3,500 vs. $5,879) compared to non-adherent patients.

Key Points: 
  • One retrospective study showed people with OSA and systolic heart failure and adherent to PAP had 24% fewer ER visits and incurred 40% lower costs related to hospitalizations and ER visits over 1 year ($3,500 vs. $5,879) compared to non-adherent patients.
  • The study analyzed 1,472 people, exactly half adherent on PAP, half non-adherent.
  • The second retrospective study showed people with OSA and diastolic heart failure and adherent to PAP had 36% fewer ER visits, 57% fewer hospitalizations, and incurred 18% lower related costs (an average $12,732 vs. $15,610) over 1 year.
  • It also found that converting a non-adherent PAP user in this study to an adherent one would save them an average 1.25 visits.

ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference

Retrieved on: 
Monday, June 5, 2023
Goldman Sachs Capital Partners, RMD, ASX, Goldman, Conference, NYSE, SAN, ResMed, Hotel, Broadcasting

SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023, beginning at approximately 9:20 a.m. (Pacific Daylight Time) at the Waldorf Astoria Monarch Beach in Dana Point, CA.

Key Points: 
  • SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023, beginning at approximately 9:20 a.m. (Pacific Daylight Time) at the Waldorf Astoria Monarch Beach in Dana Point, CA.
  • More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com .
  • The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following 180 days.